Skip to content
LevelHEALTH
Patient Portal

GLP-1 receptor agonist · Weight management

Semaglutide, explained with context.

Semaglutide is a GLP-1 receptor agonist. It is the active ingredient in several FDA-approved prescription products, each approved for specific uses. Whether it is appropriate for you is a decision made with a licensed clinician after evaluation.

Availability not yet confirmed · Educational content only

How it works

GLP-1 is a hormone involved in appetite regulation, digestion and blood sugar control. Semaglutide mimics its action, which can reduce appetite and slow stomach emptying.

That mechanism helps explain the clinical-trial findings for approved products. It does not predict how any one person will respond.

The molecule vs. a product

Approved semaglutide products have specific indications, doses and labeling. Compounded preparations are not FDA approved, are not generic equivalents and are not automatically interchangeable with approved products.

Results reported in branded clinical trials describe those products in those study populations. They are not outcomes Level Health has measured, and they should not be applied to an unstudied compounded preparation.

Evaluation first

A clinician reviews your health history, current medications, goals and any relevant testing. Being eligible for an evaluation is not the same as being eligible for a prescription.

If treatment is appropriate, it sits inside a plan that includes nutrition, movement, follow-up and coaching—not a standalone shipment.

Important safety information

  • Common effects can include nausea, vomiting, diarrhea, constipation and abdominal discomfort.
  • Approved labeling carries a boxed warning about thyroid C-cell tumors; these products are not used in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
  • Other important risks discussed in labeling include pancreatitis, gallbladder problems, low blood sugar with certain medications, kidney problems and allergic reactions.
  • Not for use during pregnancy. Your clinician will review all contraindications.

This summary is not complete. Refer to the official product labeling and talk with your clinician.

Contact a clinician or seek care if you have

  • Severe or persistent abdominal pain, with or without vomiting
  • Signs of an allergic reaction
  • A lump or swelling in the neck, trouble swallowing or persistent hoarseness
  • Signs of dehydration

For a medical emergency, call 911.

Sources

Clinical review: pending. Medical copy must be reviewed by a licensed clinician before publication.